Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile
Maria Sol Andres 🇦🇷🇬🇧

@mariasolandres1

Cardio-oncologist by day, data scientist by night. Royal Brompton Hospital. #HealthDataScience @ UofManchester. #HealthInformatics @ UCL. #Telemedicine

ID: 1092925108824494081

linkhttps://www.youtube.com/@mariasolandresMD calendar_today05-02-2019 23:17:06

1,1K Tweet

626 Followers

404 Following

European Society of Cardiology (@escardio) 's Twitter Profile Photo

📖 💖 It’s time for the next chapter in cardio-oncology… Join us for the inaugural #ESCardioOnco2025 conference, where specialists in cardiology, oncology, haematology and related fields will come together to share knowledge and build valuable connections in this dynamic and

Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

Come and visit my new You Tube channel @mariasolandresMD. It has content related to #cardiooncology both for patients and doctors. Also, share with me in the comments any content you would like to see there! #cardioonc #cardiotox

International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

Looking to kick off the new year on the right foot? Become a member of the world's leading #cardioonc society! Join #cardiooncologists from around the world in protecting patients' hearts, driving progress, and advancing your career. Sign up today: ic-os.org/BecomeAMember

Looking to kick off the new year on the right foot? 

Become a member of the world's leading #cardioonc society! Join #cardiooncologists from around the world in protecting patients' hearts, driving progress, and advancing your career.

Sign up today: ic-os.org/BecomeAMember
Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

Now watching!! Please join this webinar by #DrLyon on Cardiovascular complications of Immune Checkpoint Inhibitors. #ICI #cardiotox #cardioonc

Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

🚨Publication alert🚨 Can HF drugs be stopped after #cancer treatment and cardiac recovery? This RCT will provide some answers! 👏Congratulations to Ben Dowsing & Charlotte Manisty for leading this work! 🙏Grateful to be part of the team. 📖full study protocol : doi.org/10.1136/bmjope…

🚨Publication alert🚨
Can HF drugs be stopped after #cancer treatment and cardiac recovery? This RCT will provide some answers!
👏Congratulations to <a href="/bmdwsg/">Ben Dowsing</a>  &amp; <a href="/dr_manisty/">Charlotte Manisty</a>  for leading this work! 
🙏Grateful to be part of the team.
📖full study protocol : doi.org/10.1136/bmjope…
Cillian (@cilcomlfc) 's Twitter Profile Photo

🇮🇹 Italian Prime Minister Giorgia Meloni: "I believe in Western civilization, founded on Greek philosophy, Roman law, and Christian values." I absolutely love this woman.

drtarsh (@drtarsh) 's Twitter Profile Photo

Absolutely thrilled to have been part of a delegation from Royal Brompton and Harefield along with my esteemed colleagues # DrAlexlyon Sohaib Nazir and Maria Sol Andres 🇦🇷🇬🇧. #cardioonc #cardiooncology #medtwitter University Hospital Sharjah hosts cardiac and oncology workshop sharjah24.ae/en/Articles/20…

Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

Honoured to join Prof. Wendtner for this session hosted by @MphaR on how to prevent, recognise and manage CV complications in CLL. 🩺 Calling all haematologists and cardiologists 📍 May 14, 2025 | 13:00 CEST 🔗 Sign up here: lnkd.in/eeCM3H-t

Honoured to join Prof. Wendtner for this session hosted by @MphaR on how to prevent, recognise and manage CV complications in CLL. 
🩺 Calling all haematologists and cardiologists
 📍 May 14, 2025 | 13:00 CEST
 🔗 Sign up here: lnkd.in/eeCM3H-t
Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

🚩A deeper exploration of cardiovascular complications in Chronic Lymphocytic Leukaemia. 🎥💻Find the link to the YouTube video below. #Ondemand #cardiooncology #cardiotox #btki #ibrutinib #cll #haematooncology youtu.be/KD2mazKfkK8

Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

Honored to join #ESCardioOnco2025 as Faculty! 🎓 📍 June 20, 12:10 – Presenting on ICI-induced myocarditis 📍 June 21, 16:05 – Chairing “Innovations in Cardio-Oncology” Enjoy Florence! 💙🫀 📲 Download the App: apps.apple.com/gb/app/esc-car… #CardioOncology #HeartCancerCare

Honored to join #ESCardioOnco2025  as Faculty! 🎓

📍 June 20, 12:10 – Presenting on ICI-induced myocarditis
📍 June 21, 16:05 – Chairing “Innovations in Cardio-Oncology”
Enjoy Florence! 💙🫀
📲 Download the App: apps.apple.com/gb/app/esc-car…

#CardioOncology #HeartCancerCare
Novi Yanti Sari (@slumberbell) 's Twitter Profile Photo

What to do in challenging cases of #ICI #myocarditis?🫀 Outstanding take-home messages from Maria Sol Andres 🇦🇷🇬🇧 at #ESCardioOnco2025 💡 📍One of the most severe immune-related adverse events➡️high mortality if not treated early 📍Risk factors: combination ICI therapy & other irAEs

Clara Llamedo, MD (@llamedoclara) 's Twitter Profile Photo

Fantastic session on challenging CV cases linked to immunotherapy — it’s not just myocarditis! Late complications like accelerated atherosclerosis are key issues we mustn’t overlook Maria Sol Andres 🇦🇷🇬🇧 DrJE-Salem Wouter Meijers European Society of Cardiology

Fantastic session on challenging CV cases linked to immunotherapy — it’s not just myocarditis! Late complications like accelerated atherosclerosis are key issues we mustn’t overlook <a href="/MariaSolAndres1/">Maria Sol Andres 🇦🇷🇬🇧</a> <a href="/DrJESalem/">DrJE-Salem</a> <a href="/WCFWMeijers/">Wouter Meijers</a> <a href="/escardio/">European Society of Cardiology</a>
Maria Sol Andres 🇦🇷🇬🇧 (@mariasolandres1) 's Twitter Profile Photo

#ESCardioOnco2025 has come to an end. 880 attendees, 2 days full of activities, dozens of research studies presented and tons of time to meet old friends and make new ones. The bad news: the conference has finished, the good news: this was the first of many more to come!!

#ESCardioOnco2025 has come to an end. 880 attendees, 2 days full of activities, dozens of research studies presented and tons of time to meet old friends and make new ones.  The bad news: the conference has finished, the good news: this was the first of many more to come!!